Olanzapine is a relatively new antipsychotic agent which appears to be effective in the treatment of both the positive and negative symptoms of schizophrenia. Reported here is the case of a patient who developed symptoms of mania secondary to treatment with olanzapine. Physicians prescribing olanzapine should be aware of this potential complication.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/jom-1998-0101 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Olanzapine-induced oculogyric crisis in a patient with mania without psychotic symptoms: a case report.
Ann Med Surg (Lond)
October 2023
Department of Psychiatry, MD, BP Koirala Institute of Health Sciences (BPKIHS), Nepal.
Introduction And Importance: Oculogyric crisis (OGC), marked by upward eye deviation, is rare and linked to diverse causes, including drugs and neurological conditions. This study details a 16-year-old male's OGC onset after olanzapine treatment for an initial mania episode, highlighting the need to recognize this potential side effect.
Case Presentation: A 16-year-old male with nonpsychotic mania was treated with olanzapine and sodium valproate.
Olanzapine-induced mania.
J Osteopath Med
October 1998
Chief of Psychiatry (116A), G. V. (Sonny) Montgomery VA Medical Center, 1500 E Woodrow Wilson Dr, Jackson, MS39216. USA.
Olanzapine is a relatively new antipsychotic agent which appears to be effective in the treatment of both the positive and negative symptoms of schizophrenia. Reported here is the case of a patient who developed symptoms of mania secondary to treatment with olanzapine. Physicians prescribing olanzapine should be aware of this potential complication.
View Article and Find Full Text PDFA 67-year-old male presented with symptoms of mania eight days after switching from sertraline to bupropion. His past medical history included benign prostatic hyperplasia, erectile dysfunction, insomnia, and a recent diagnosis of depression. He denied previous history of depression but reported taking sertraline for premature ejaculation, an off-label use.
View Article and Find Full Text PDFOlanzapine-induced Skin Eruptions.
Indian J Psychol Med
January 2017
Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Adverse cutaneous reactions are known to occur with psychotropic medications, which may lead to poor drug compliance. As compared to other group of psychotropics, there is relatively scarce literature on olanzapine-induced skin eruptions. We present a case of a 39-year-old man diagnosed with first episode mania and alcohol dependence syndrome who was started on tablet olanzapine which leads to fixed drug eruptions.
View Article and Find Full Text PDFMelatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial.
Acta Med Iran
July 2015
Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Olanzapine is the frequently prescribed drug in children and adolescents with bipolar disorder, but unfortunately it has metabolic side-effects. On the other hand, in a number of melatonin studies on sleep cycle, regulation of metabolic abnormalities has been reported. Therefore, we aimed to study effects of melatonin in reducing metabolic side-effects of olanzapine in 11-17 year-old patients with bipolar disorder.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!